RESEARCH TRIANGLE PARK, NC, March 18, 2008 - Clinipace, a growing on-demand clinical research software company, announced that Hampton Corley has joined the company as Vice President, Business Development. Corley reports to Chief Operating Officer, Chris Porter, and is tasked with building and managing the company’s sales organization.
Chris Porter, Chief Operating Officer of Clinipace, describes the company’s overall sales strategy during this high-growth stage, “In order to achieve our desired sales and company growth it is imperative that we intensely focus our sales efforts on post-approval research, registries, and investigator-initiated research management within the biopharmaceutical, medical device and academic medical research segments. Hampton has been an extraordinarily successful sales executive and manager his entire career and is passionate about selling the right product to the right customers to ensure their success.” Porter continues, “We are thrilled to have Hampton join our management team and lead our sales organization. With over thirteen years of experience in selling software, business service, and analytics solutions, Hampton is a world-class salesperson who has worked for some of the best known sales organizations.”
Most recently Hampton led sales at PSIMedica, a subsidiary of Bio-Reference Laboratories, and came to appreciate the value of collecting and managing data for clinical utilization in an efficient, scalable, and affordable manner. “It was very important that we bring in a sales leader that understands clinical data and has the experience, discipline and desire to scale our business and build our sales organization,” explains Porter.
Prior to PSIMedica, the healthcare analytics division of Bio-Reference Laboratories, Corley served in different sales roles at Ariba, GeoTel Communications (acquired by Cisco Systems), and PTC.
About Clinipace: Clinipace is a clinical research software company providing a single, integrated data capture and study management platform for post-approval research and registries conducted by biopharmaceutical and medical device companies, Clinical Research Organizations (CROs) and Academic Medical Centers (AMCs). Our platform, called Tempo, is delivered via a web-based, on-demand architecture that streamlines the clinical research process by eliminating the integration headaches associated with multiple platforms, reducing project efforts and costs from startup to conclusion, and empowering project stakeholders to make informed real-time decisions regarding their research. For more information on Clinipace, please visit: www.clinipace.com Media Contact: David Levin Clinipace, Inc. dlevin@clinipace.com919.724.4043
